The circular long awaited, announced by minister Roberto Speranza, arrives shortly after midnight on Thursday, with the signature of the Director General of the Ministry of Health, Gianni Rezza. A few lines in which it is recalled that the AstraZeneca vaccine, renamed Vaxzevria, is approved from 18 years of age, but it is recommended “preferential use in people over 60 years of age“. And this is because in the more advanced age groups there is a “low risk of adverse reactions of the thromboembolic type compared to the high mortality from COVID-19”.
The indication is clear and will certainly have an impact on the Italian vaccination campaign, but the government’s intention is not to upset the national plan and go straight ahead, in line with Palazzo Chigi’s choice of give priority to older people. The circular also answers one of the many questions raised by the EMA’s change of course: who received the first dose, need to change medication? For the Ministry of Health no, he can go without fear to complete the immunization: “By virtue of the data available to date, those who have already received a first dose of the Vaxzevria vaccine can complete the vaccination course with the same vaccine “.
April 8, 2021 (change April 8, 2021 | 00:54)
© REPRODUCTION RESERVED